Recent Quotes (30 days)

You have no recent quotes
chg | %

Angel Biotechnology Holdings Plc news

   Watch this stock
Showing stories 1 - 10 of about 71   

Articles published

ABH 0.0500
price chart
Angel Biotechnology calls in administrators
The company has a subsidiary, Angel Biomedical, which is also in administration. Share-trading in AIM-listed Angel Biotechnology Holdings has ceased. KPMG said the companies had incurred losses, most recently as a result of difficult trading conditions.
Related articles »  
Collagen Solutions co-founder Dr Stewart White is stepping down
In 2011 the assets were sold to Angel Biotechnology Holdings Plc, which was placed into administration in 2013. In 2013 Dr White secured backing for a new venture, Collbio from life sciences investment firm Diagnostic Capital to acquire the collagen ...
Collagen Solutions' pre-tax losses widen to �1.61m
Collagen Solutions reports pre-tax losses widened to �1.61m for the 2017 year to March despite group revenue rising 26 per cent to �3.94m.
Collagen Solutions moves up the medtech value chain  Proactive Investors UK
Legal & General Group Plc Has Trimmed Its Celanese Del (CE) Position; Resolute ...
Angel Biotechnology Holdings Plc is a specialist biopharmaceutical manufacturing company. The company has market cap of 1.89 million GBP.
Resolute Forest Products Inc (LON:ABH) Institutional Investor Sentiment Trend
Resolute Forest Products Inc (LON:ABH) institutional sentiment increased to 1 in 2016 Q4. Its up 0.02, from 0.98 in 2016Q3. The ratio is more positive, as 45 funds increased and started new stock positions, while 45 sold and decreased their stakes in ...
SP Angel repeats 'buy' recommendation for Union Jack Oil after its latest deal
Stockbroker SP Angel has repeated a 'buy' recommendation for Union Jack Oil PLC (LON:UJO) following its latest deal to grow it onshore UK oil business.
Scancell's SCIB1 cancer treatment continues to produce strong survival data
Scancell Holdings Plc (LON:SCLP) has told investors that its SCIB1 skin cancer treatment continues to produce remarkable survival data from the ongoing phase I/II clinical trial.
Sareum marks progress with first profit
Cash holdings were �2.34mln (�335,000). Importantly, with development funding for Chk1 now arranged it frees the company up to accelerate work at its three other programmes and especially TYK2 a compound that is targeting psoriasis, rheumatoid ...
New Mountain Vantage Advisers Cut Equity Comwlth (EQC) Holding; Resolute ...
Angel Biotechnology Holdings Plc is a specialist biopharmaceutical manufacturing company. The company has market cap of 1.89 million GBP.
Howard Hughes Medical Institute Trimmed By $821905 Its Apple (AAPL) Holding ...
Angel Biotechnology Holdings Plc is a specialist biopharmaceutical manufacturing company. The company has market cap of 1.89 million GBP.